Gilead


Also found in: Dictionary, Wikipedia.
Related to Gilead: balm of Gilead

Gilead

(gĭl`ēăd), in the Bible. 1 Eponym of the Gileadites, grandson of Manasseh. 2 Gadite. 3 Jephthah's father. 4 City near Mizpah, denounced by HoseaHosea
, prophetic book of the Bible. It relates something of the career of the prophet Hosea who preached against the sins of the northern kingdom of Israel in the third quarter of the 8th cent. B.C.
..... Click the link for more information.
. 5 Fertile, mountainous region, NE of the Dead Sea. In the Bible, it was allotted to Reuben, Gad, and Manasseh and was noted for its spices, myrrh, and balm. It was the home of Jair, Jephthah, and Elijah, and here Jacob met Laban; Ishbosheth was once its king, and in it David found refuge from Absalom. After the partition of Israel it became part of the northern kingdom. It was captured by Assyria. Hosea denounced it. It has been called variously Mt. Gilead, Land of Gilead, and Gilead.

Gilead

1
a historic mountainous region east of the River Jordan, rising over 1200 m (4000 ft.)

Gilead

2
Old Testament a grandson of Manasseh; ancestor of the Coileadites (Numbers 26: 29--30)
References in periodicals archive ?
In March 2002, Gilead announced the initiation of an early access program in the United States to provide adefovir dipivoxil to chronic hepatitis B patients with lamivudine-resistant HBV.
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases worldwide.
Tenofovir's safety profile is considerably improved over adefovir, a closely related compound developed by Gilead.
Gilead scientists are reporting almost identical preliminary results from a similar 552-person phase III treatment-intensification trial.
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.
All forward-looking statements are based on information currently available to Gilead, and Gilead assumes no obligation to update any such forward-looking statements.
For more information on Gilead, please call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235) or visit www.
Under the terms of the agreement, Gilead will provide to both IPM and CONRAD a royalty-free license to develop and, if proven efficacious, distribute tenofovir as a microbicide in approximately 100 resource-limited countries hardest hit by the HIV epidemic.
On November 17, 2006, Gilead caused one of its wholly-owned subsidiaries to be merged into Myogen.
As previously announced on October 2, 2006, Gilead and Myogen entered into a definitive merger agreement for Gilead to acquire all of the outstanding shares of common stock of Myogen for $52.
All forward-looking statements are based on information currently available to Gilead and Gilead assumes no obligation to update any such forward-looking statements or other statements included in this press release.
Gilead and Myogen believe data from two completed pivotal Phase III studies (ARIES 1&2) evaluating the safety and efficacy of the product as a potential treatment for PAH would support a New Drug Application (NDA).